Microbix Biosystems Inc. , a life sciences innovator, manufacturer, and exporter, announces that it will be presenting to equity investors at the Whistler Capital Event conference, organized by ...
Thetis Pharmaceuticals LLC ("Thetis"), a clinical-stage company developing TP-317, a first-in-class, small molecule drug candidate targeting the BLT1 receptor to treat inflammatory bowel disease (IBD) ...
A genetic mutation found in two human patients with schizophrenia also increased schizophrenia-related behaviors in mice with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback